West Pharmaceutical Servi... (WST)
Company Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
It operates in two segments, Proprietary Products and Contract-Manufactured Products.
The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components.
It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support.
This segment serves biologic, generic, and pharmaceutical drug companies.
The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
It serves pharmaceutical, diagnostic, and medical device companies.
The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors.
West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Country | United States |
IPO Date | Mar 17, 1980 |
Industry | Medical - Instruments & Supplies |
Sector | Healthcare |
Employees | 10,600 |
CEO | Eric M. Green |
Contact Details
Address: 530 Herman O. West Drive Exton, Pennsylvania United States | |
Website | https://www.westpharma.com |
Stock Details
Ticker Symbol | WST |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000105770 |
CUSIP Number | 955306105 |
ISIN Number | US9553061055 |
Employer ID | 23-1210010 |
SIC Code | 3060 |
Key Executives
Name | Position |
---|---|
Eric M. Green | Non-Independent Chair of the Board, President & Chief Executive Officer |
Bernard J. Birkett | Senior Vice President & Chief Financial Officer |
Aileen Kinsella | Head of Proprietary Product Sales |
Aileen Ruff-Patry | President of Contract Manufacturing |
Andy Polywacz | President of Integrated Systems |
Charles Witherspoon CPA | Vice President & Treasurer |
Don O'Callaghan | President of Drug Delivery Devices |
Kathy DePadua | Senior Vice President and Chief Quality & Regulatory Officer |
Kimberly Banks MacKay | Senior Vice President, General Counsel & Company Secretary |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 21, 2025 | ARS | Filing |
Mar 21, 2025 | DEFA14A | Filing |
Mar 21, 2025 | DEF 14A | Filing |
Mar 11, 2025 | PRE 14A | Filing |
Mar 11, 2025 | 8-K | Current Report |
Feb 20, 2025 | 4 | Filing |
Feb 20, 2025 | 4 | Filing |
Feb 20, 2025 | 4 | Filing |
Feb 20, 2025 | 4 | Filing |
Feb 20, 2025 | 4 | Filing |